Beyond digestive symptoms, some people report fatigue, headaches, or dizzinessespecially early in treatment when the body is adapting to changes in appetite and food intake
The studies presented at SNIS 2025 provide early signals that GLP-1 inhibitors could lessen the impact of strokes and complications resulting from brain injuries, and may even reduce stroke risks altogether
GLP-1 medications have transformed the clinical management of type 2 diabetes and obesity by reducing associated morbidity and mortality
Nicolau syndrome (NS) also known as Embolia cuits medicamentosa (ECM) or livedo-like dermatitis (LLD) is a rare serious skin condition characterized by sudden-onset pain, skin changes, and tissue necrosis caused by medications injected into the muscle or subcutaneous tissue
Diagnsticos complementarios: hemograma, perfil heptico, glucosa, lpidos y ecografa abdominal para descartar comorbilidades
[DOI] [PubMed] [Google Scholar] 125.Twardzik D.R., Peterkofsky A